The average launch prices for new brand-name drugs and new generic drugs have skyrocketed since 2006, according to an  from 46brooklyn, a drug research firm. Using data from Elsevier's Gold Standard Drug Database and the federal government, the analysis found that the median monthly price of a new brand-name drug increased 381% (from $150 to $722) from 2006-2019 while the median monthly price of a new generic drug increased 712% (from about $100 to almost $800) during that period. The report also found that nearly 80% of all generic drugs studied had no decrease in their average wholesale price in the past five years.

Related News Articles

Headline
The White House April 15 released an executive order directing federal agencies to undertake a broad range of tasks aimed at reducing the costs of prescription…
Headline
The Department of Commerce yesterday released notices announcing national security investigations on imports of pharmaceuticals, pharmaceutical ingredients and…
Headline
The AHA Feb. 28 filed a friend-of-the-court brief in the U.S. Court of Appeals for the 4th Circuit, urging the court to affirm a decision by the U.S. District…
Headline
Sens. Dick Durbin, D-Ill., and Chuck Grassley, R-Iowa, Jan. 23 introduced the Drug-price Transparency for Consumers Act, legislation supported by the AHA that…
Headline
The Department of Health and Human Services Jan. 17 announced 15 Medicare Part D drugs selected for the latest round of price negotiations. Negotiations will…
Headline
Prices for the top 25 brand-name Medicare Part D drugs have increased by an average of 98% since entering the market, according to a report released Jan. 9 by…